Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion type Assertion NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_head.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion evidence source_evidence_literature NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion SIO_000772 16232198 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion wasDerivedFrom befree-20140225 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion wasGeneratedBy ECO_0000203 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.